In episode #8, we invited a mental health scientist to discuss the effects of the COVID-19 pandemic in terms of anxiety and depression in the overall population, as well as the latest advancements in pharmacogenomics as the industry moves to a more personalized approach. Our guest, Dr. Tony Ortiz is the founder, principal investigator and scientific director at NRC Research Institute where he oversees the day to day clinical research for psychiatric indications for depression, bipolar disorder, schizophrenia, and attention deficit hyperactivity disorder.
----------------------------------------------------------------------------------------------------
JOIN THE MOVEMENT:
GLLG Company Website: https://www.glennllopis.com/
Age Of Personalization Website: https://ageofpersonalization.com/
Contact Us: https://www.glennllopis.com/contact-us/
Email Us: sandy@glennllopisgroup.com
FOLLOW GLENN LLOPIS:
LinkedIn: https://bit.ly/3tnBmP9
Instagram: https://bit.ly/3fcziRV
Facebook: https://bit.ly/33sCg1K
Twitter: https://bit.ly/3HVT14B